vs

Side-by-side financial comparison of Kellanova (K) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.

Kellanova is the larger business by last-quarter revenue ($3.3B vs $2.1B, roughly 1.6× Zimmer Biomet). Zimmer Biomet runs the higher net margin — 11.4% vs 9.5%, a 1.9% gap on every dollar of revenue. On growth, Zimmer Biomet posted the faster year-over-year revenue change (9.3% vs 0.8%). Kellanova produced more free cash flow last quarter ($359.0M vs $245.9M). Over the past eight quarters, Zimmer Biomet's revenue compounded faster (3.7% CAGR vs -9.0%).

Kellanova, formerly known as the Kellogg Company, is an American multinational food manufacturing company owned by Mars Inc. headquartered in Chicago, Illinois. The renaming took effect on October 2, 2023, and the company's North American cereal operations were spun off to form the WK Kellogg Co at the same time.

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

K vs ZBH — Head-to-Head

Bigger by revenue
K
K
1.6× larger
K
$3.3B
$2.1B
ZBH
Growing faster (revenue YoY)
ZBH
ZBH
+8.5% gap
ZBH
9.3%
0.8%
K
Higher net margin
ZBH
ZBH
1.9% more per $
ZBH
11.4%
9.5%
K
More free cash flow
K
K
$113.1M more FCF
K
$359.0M
$245.9M
ZBH
Faster 2-yr revenue CAGR
ZBH
ZBH
Annualised
ZBH
3.7%
-9.0%
K

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
K
K
ZBH
ZBH
Revenue
$3.3B
$2.1B
Net Profit
$309.0M
$238.3M
Gross Margin
33.3%
64.6%
Operating Margin
13.9%
17.9%
Net Margin
9.5%
11.4%
Revenue YoY
0.8%
9.3%
Net Profit YoY
-15.8%
30.5%
EPS (diluted)
$0.88
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
K
K
ZBH
ZBH
Q1 26
$2.1B
Q4 25
$2.2B
Q3 25
$3.3B
$2.0B
Q2 25
$3.2B
$2.1B
Q1 25
$3.1B
$1.9B
Q4 24
$3.1B
$2.0B
Q3 24
$3.2B
$1.8B
Q2 24
$3.2B
$1.9B
Net Profit
K
K
ZBH
ZBH
Q1 26
$238.3M
Q4 25
$139.4M
Q3 25
$309.0M
$230.9M
Q2 25
$299.0M
$152.8M
Q1 25
$304.0M
$182.0M
Q4 24
$365.0M
$239.5M
Q3 24
$367.0M
$249.1M
Q2 24
$344.0M
$242.8M
Gross Margin
K
K
ZBH
ZBH
Q1 26
64.6%
Q4 25
64.7%
Q3 25
33.3%
72.1%
Q2 25
34.0%
71.5%
Q1 25
34.3%
71.2%
Q4 24
37.7%
71.0%
Q3 24
36.4%
70.5%
Q2 24
36.4%
71.5%
Operating Margin
K
K
ZBH
ZBH
Q1 26
17.9%
Q4 25
6.9%
Q3 25
13.9%
17.6%
Q2 25
13.7%
14.4%
Q1 25
13.9%
15.3%
Q4 24
17.0%
19.2%
Q3 24
14.1%
15.3%
Q2 24
15.4%
18.1%
Net Margin
K
K
ZBH
ZBH
Q1 26
11.4%
Q4 25
6.2%
Q3 25
9.5%
11.5%
Q2 25
9.3%
7.4%
Q1 25
9.9%
9.5%
Q4 24
11.7%
11.8%
Q3 24
11.4%
13.7%
Q2 24
10.8%
12.5%
EPS (diluted)
K
K
ZBH
ZBH
Q1 26
$1.22
Q4 25
$0.71
Q3 25
$0.88
$1.16
Q2 25
$0.85
$0.77
Q1 25
$0.87
$0.91
Q4 24
$1.05
$1.18
Q3 24
$1.05
$1.23
Q2 24
$1.00
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
K
K
ZBH
ZBH
Cash + ST InvestmentsLiquidity on hand
$240.0M
$424.2M
Total DebtLower is stronger
$4.3B
$7.5B
Stockholders' EquityBook value
$4.2B
$12.7B
Total Assets
$15.6B
$22.7B
Debt / EquityLower = less leverage
1.02×
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
K
K
ZBH
ZBH
Q1 26
$424.2M
Q4 25
$591.9M
Q3 25
$240.0M
$1.3B
Q2 25
$354.0M
$556.9M
Q1 25
$330.0M
$1.4B
Q4 24
$694.0M
$525.5M
Q3 24
$569.0M
$569.0M
Q2 24
$272.0M
$420.1M
Total Debt
K
K
ZBH
ZBH
Q1 26
$7.5B
Q4 25
Q3 25
$4.3B
Q2 25
$4.3B
Q1 25
$5.0B
Q4 24
$5.0B
Q3 24
$5.1B
Q2 24
$5.0B
Stockholders' Equity
K
K
ZBH
ZBH
Q1 26
$12.7B
Q4 25
$12.7B
Q3 25
$4.2B
$12.8B
Q2 25
$4.1B
$12.5B
Q1 25
$3.9B
$12.4B
Q4 24
$3.8B
$12.5B
Q3 24
$3.6B
$12.4B
Q2 24
$3.3B
$12.7B
Total Assets
K
K
ZBH
ZBH
Q1 26
$22.7B
Q4 25
$23.1B
Q3 25
$15.6B
$23.5B
Q2 25
$15.9B
$22.9B
Q1 25
$15.5B
$22.2B
Q4 24
$15.6B
$21.4B
Q3 24
$15.8B
$21.7B
Q2 24
$15.3B
$21.5B
Debt / Equity
K
K
ZBH
ZBH
Q1 26
0.59×
Q4 25
Q3 25
1.02×
Q2 25
1.05×
Q1 25
1.28×
Q4 24
1.32×
Q3 24
1.40×
Q2 24
1.51×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
K
K
ZBH
ZBH
Operating Cash FlowLast quarter
$503.0M
$359.4M
Free Cash FlowOCF − Capex
$359.0M
$245.9M
FCF MarginFCF / Revenue
11.0%
11.8%
Capex IntensityCapex / Revenue
4.4%
Cash ConversionOCF / Net Profit
1.63×
1.51×
TTM Free Cash FlowTrailing 4 quarters
$599.0M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
K
K
ZBH
ZBH
Q1 26
$359.4M
Q4 25
$517.4M
Q3 25
$503.0M
$418.7M
Q2 25
$169.0M
$378.2M
Q1 25
$116.0M
$382.8M
Q4 24
$467.0M
$506.3M
Q3 24
$553.0M
$395.7M
Q2 24
$376.0M
$369.4M
Free Cash Flow
K
K
ZBH
ZBH
Q1 26
$245.9M
Q4 25
$442.6M
Q3 25
$359.0M
$363.7M
Q2 25
$21.0M
$328.1M
Q1 25
$-60.0M
$338.2M
Q4 24
$279.0M
$454.8M
Q3 24
$410.0M
$351.2M
Q2 24
$234.0M
$316.7M
FCF Margin
K
K
ZBH
ZBH
Q1 26
11.8%
Q4 25
19.7%
Q3 25
11.0%
18.2%
Q2 25
0.7%
15.8%
Q1 25
-1.9%
17.7%
Q4 24
8.9%
22.5%
Q3 24
12.7%
19.3%
Q2 24
7.3%
16.3%
Capex Intensity
K
K
ZBH
ZBH
Q1 26
Q4 25
3.3%
Q3 25
4.4%
2.7%
Q2 25
4.6%
2.4%
Q1 25
5.7%
2.3%
Q4 24
6.0%
2.5%
Q3 24
4.4%
2.4%
Q2 24
4.4%
2.7%
Cash Conversion
K
K
ZBH
ZBH
Q1 26
1.51×
Q4 25
3.71×
Q3 25
1.63×
1.81×
Q2 25
0.57×
2.48×
Q1 25
0.38×
2.10×
Q4 24
1.28×
2.11×
Q3 24
1.51×
1.59×
Q2 24
1.09×
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

K
K

Retail Channel Snacks$2.0B62%
Retail Channel Cereal$678.0M21%
Noodlesand Other$280.0M9%
Frozen And Specialty Channels$275.0M8%

ZBH
ZBH

Segment breakdown not available.

Related Comparisons